NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-.
CASRN: 135326-11-3
Drug Levels and Effects
Summary of Use during Lactation
There is no published experience with gadoxetate during breastfeeding. Guidelines developed by several North American professional organizations state that breastfeeding need not be disrupted after a nursing mother receives a gadolinium-containing contrast medium.[1-3] However, because there is no published experience with gadoxetate during breastfeeding, other agents may be preferred, especially while nursing a newborn or preterm infant.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
Gadobenate, Gadobutrol, Gadopentetate, Gadoteridol, Gadoterate
References
- 1.
- American College of Radiology Committee on Drugs and Contrast Media. Administration of contrast media to breast-feeding mothers. In, ACR manual on contrast media. 2018;Version 10.3:99. https://www
.acr.org/- /media/ACR/Files/Clinical-Resources /Contrast_Media.pdf. Accessed Oct 7, 2019. - 2.
- Patenaude Y, Pugash D, Lim K, et al. The use of magnetic resonance imaging in the obstetric patient. J Obstet Gynaecol Can. 2014;36:349–63. [PubMed: 24798674]
- 3.
- Copel J, El-Sayed Y, Heine RP, et al. Committee Opinion No. 723: Guidelines for diagnostic imaging during pregnancy and lactation. Obstet Gynecol. 2017;130:e210–e216. [PubMed: 28937575]
Substance Identification
Substance Name
Gadoxetate
CAS Registry Number
135326-11-3
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- LactMed App
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- PubMedLinks to PubMed
- Review Gadopentetate[Drugs and Lactation Database (...]Review Gadopentetate. Drugs and Lactation Database (LactMed). 2006
- Review Gadoversetamide[Drugs and Lactation Database (...]Review Gadoversetamide. Drugs and Lactation Database (LactMed). 2006
- Review Gadofosveset[Drugs and Lactation Database (...]Review Gadofosveset. Drugs and Lactation Database (LactMed). 2006
- Review Gadobenate[Drugs and Lactation Database (...]Review Gadobenate. Drugs and Lactation Database (LactMed). 2006
- Review Gadodiamide[Drugs and Lactation Database (...]Review Gadodiamide. Drugs and Lactation Database (LactMed). 2006
- Gadoxetate - Drugs and Lactation Database (LactMed)Gadoxetate - Drugs and Lactation Database (LactMed)
Your browsing activity is empty.
Activity recording is turned off.
See more...